Table 3.
Associations between participant symptom complaints at 12-month follow-up and randomization into the contingency management intervention (n = 104)a
| Somatization b (95% CI) |
Obsessive-Compulsive b (95% CI) |
Interpersonal Sensitivity b (95% CI) |
Depression b (95% CI) |
Anxiety b (95% CI) |
Hostility b (95% CI) |
Phobic Anxiety b (95% CI) |
Paranoid Ideation b (95% CI) |
Psychoticism b (95% CI) |
|
|---|---|---|---|---|---|---|---|---|---|
| CM Intervention | −0.32* ([−0.62] – [−0.01]) | −0.40** ([−0.70] – [−0.11]) | −0.38* ([−0.71] – [−0.05]) | −0.40* ([−0.73] – [−0.06]) | −0.45** ([−0.76] – [−0.14]) | −0.38* ([−.74] – [−0.02]) | −0.44* ([−0.80] – [−0.09]) | −0.61*** ([−0.94] – [−0.29]) | −0.55** ([−0.93] – [−0.17]) |
| R2 | 0.26 | 0.23 | 0.25 | 0.22 | 0.38 | 0.17 | 0.23 | 0.36 | 0.26 |
a
nControl = 49; nCM = 55
*
≤ 0.05;
**
p ≤ 0.01;
***
p ≤ 0.001; all sig. tests 2-tailed
Statistical controls: Substance abstinence during intervention phase (urinalysis/breathalyzer confirmed), baseline symptom complaints (domain-specific), participant race/ethnicity, age, and HIV status
CM Omnibus test of significance (i.e., contingency management intervention b = 0 across all symptom domains): χ2(9) = 17.26; p < 0.05